Nathaniel Sisitsky compensation by year
STAAR SURGICAL Summary Compensation Table · all 2 fiscal years held| Component | FY2024 | FY2025 |
|---|---|---|
| Salary | $470,000 | $488,750 |
| Bonus | $0 | $75,000 |
| Stock awards | $1,315,970 | $1,800,036 |
| Option awards | $328,991 | $0 |
| Non-equity incentive | $0 | $381,150 |
| Pension and deferred compensation | $0 | $0 |
| All other | $16,974 | $21,026 |
| Total | $2,131,935 | $2,765,962 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: STAAR SURGICAL CO DEF 14A filed May 4, 2026, accession 0000718937-26-000015, and prior-year filings.
How this page was built: the STAAR SURGICAL CO filed document, accession 0000718937-26-000015. Every figure is read from that document and cited to the page and table it appears in. Filed May 4, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 52,787 | $1,245,773 | — |
| RSU | 52,787 | $1,245,773 | — |
| RSU | 11,654 | $275,034 | — |
| RSU | 7,312 | $172,563 | — |
| Option | 6,524 | — | $37.64 |
| Option | 13,287 | — | $32.14 |
Per the Outstanding Equity Awards at Fiscal Year-End table in STAAR SURGICAL CO's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments STAAR SURGICAL discloses, by trigger · FY2026| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control and involuntary termination | $1,039,500 | $2,939,144 | $37,203 | $4,015,847 |
| Involuntary termination without cause | $495,000 | $0 | $37,203 | $532,203 |
| Change in control, no termination | $0 | $2,939,144 | $0 | $2,939,144 |
Per the Potential Payments Upon Termination or Change in Control table in STAAR SURGICAL CO's FY2026 proxy. Estimates as the company printed them; a dash means it printed no figure.
STAAR SURGICAL’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Stephen Farrell | Chief Executive Officer | $7,522,385 |
| Warren Foust | President and Chief Operating Officer | $4,440,664 |
| Nathaniel Sisitsky · this page | Chief Legal Officer and Corporate Secretary | $2,765,962 |
| Magda Michna | Chief Development Officer | $2,695,752 |
| Deborah Andrews | Chief Financial Officer | $2,582,411 |
| Thomas Frinzi | Former President and Chief Executive Officer | $1,255,915 |
| Patrick Williams | Former Chief Financial Officer | $926,941 |
Nathaniel Sisitsky's compensation dossier, STAAR SURGICAL
You have read Nathaniel Sisitsky's totals and holdings. The dossier adds each equity grant STAAR SURGICAL disclosed for Nathaniel Sisitsky and STAAR SURGICAL's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full STAAR SURGICAL compensation record
free company briefThis page is one person within STAAR SURGICAL's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the STAAR SURGICAL proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order STAAR SURGICAL's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are STAAR SURGICAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.